TrialPharmacoEconomics2010

Q-TWiST analysis of patients receiving temsirolimus or interferon alpha for treatment of advanced renal cell carcinoma.

Arthur S Zbrozek et al.PubMed ↗Publisher ↗

No numbers read from the abstract.